Correction to: Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review
Jan 2023
Habiba, Ume , Waseem, Radeyah , Shaikh, Taha Gul , Waseem, Summaiyya , Ahmed, Syed Hassan , Asghar, Muhammad Sohaib
Correction to: Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review
Neurological Sciences
https://doi.org/10.1007/s10072-023-06626-x
CORRECTION
Correction to: Comparative efficacy and safety of lemborexant 5 mg
versus 10 mg for the treatment of insomnia: a systematic review
Ume Habiba1 · Radeyah Waseem1 · Taha Gul Shaikh1 · Summaiyya Waseem1 · Syed Hassan Ahmed1 ·
Muhammad Sohaib Asghar2
© Fondazione Società Italiana di Neurologia 2023
Correction to: Neurological Sciences (2023)
https://doi.org/10.1007/s10072-023-06601-6
The above article was published with error. Figure 1
(PRISMA Flowchart) has been replaced with the incorrect
figure during correction stage.
The Original article has been corrected.
Publisher's note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
The original article can be found online at https://doi.org/10.1007/
s10072-023-06601-6.
* Muhammad Sohaib Asghar
1
Dow University of Health Sciences, Karachi, Pakistan
2
Division of Nephrology and Hypertension, Mayo Clinic,
Rochester, MN, USA
13
Vol.:(0123456789)
(...truncated)
This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007/s10072-023-06626-x.pdf
Article home page: https://link.springer.com/article/10.1007/s10072-023-06626-x
Habiba, Ume, Waseem, Radeyah, Shaikh, Taha Gul, Waseem, Summaiyya, Ahmed, Syed Hassan, Asghar, Muhammad Sohaib.
Correction to: Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review ,
2023, pp. 1, DOI: 10.1007/s10072-023-06626-x